50090-0963 : Rifampin 300 mg Oral Capsule


NDC: 50090-0963
Labeler: A-s Medication Solutions
Product Type: Human Prescription Drug
Drug Name:  Rifampin
Dosage Form: Oral Capsule
Application #: ANDA065390
Rev. Date: 


Appearance:


Markings: LANNETT;1315
Shapes:  Capsule
Colors:  Red
Size (mm): 19
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

LANNETT 1315: (0527-1315) Rifampin 300 mg Oral Capsule by A-s Medication Solutions
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 50090-0963-0: 30 CAPSULE IN 1 BOTTLE (50090‑0963‑0)
  • 50090-0963-3: 60 CAPSULE IN 1 BOTTLE (50090‑0963‑3)

Active Ingredients:

  • Rifampin

Dosage Strength:

  • 300 mg

Inactive Ingredients:

  • Starch, Corn
  • Silicon Dioxide
  • Talc
  • Magnesium Stearate
  • Gelatin, Unspecified
  • Titanium Dioxide
  • D&c Red No. 28
  • Fd&c Red No. 40
  • Fd&c Blue No. 1
  • Shellac
  • Alcohol
  • Ferrosoferric Oxide
  • Butyl Alcohol
  • Propylene Glycol
  • Methyl Alcohol
  • Aluminum Oxide
  • Fd&c Blue No. 2
  • D&c Yellow No. 10

Pharmaceutical Classes:

  • Rifamycin Antibacterial [EPC]
  • Rifamycins [Chemical/Ingredient]

Related Products:

Based on records with the same trade name.
  • 50090-0964 Rifampin 300 mg Oral Capsule by A-s Medication Solutions
  • 50090-1268 Rifampin 150 mg Oral Capsule by A-s Medication Solutions
  • 50090-2633 Rifampin 150 mg Oral Capsule by A-s Medication Solutions
  • 50090-4961 Rifampin 300 mg Oral Capsule by A-s Medication Solutions
  • 50090-5709 Rifampin 300 mg Oral Capsule by A-s Medication Solutions
  • 54569-5770 Rifampin 300 mg Oral Capsule by A-s Medication Solutions
  • 0069-0112 Rifampin 600 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-0141 Rifampin 600 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Pfizer Laboratories Div Pfizer Inc
  • 0143-9230 Rifampin 600 mg Intravenous Injection, Powder, Lyophilized, for Solution by West-ward Pharmaceuticals Corp
  • 0185-0799 Rifampin 300 mg Oral Capsule by Eon Labs, Inc.
  • 0185-0801 Rifampin 150 mg Oral Capsule by Eon Labs, Inc.
  • 0527-1315 Rifampin 300 mg Oral Capsule by Lannett Company, Inc.
  • 0527-1393 Rifampin 150 mg Oral Capsule by Lannett Company, Inc.
  • 0904-5282 Rifampin 300 mg Oral Capsule by Major Pharmaceuticals
  • 17478-151 Rifampin 600 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Akorn Inc.
  • 17478-155 Rifampin 600 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Akorn
  • 21695-527 Rifampin 300 mg Oral Capsule by Rebel Distributors Corp
  • 23155-340 Rifampin 600 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Heritage Pharmaceuticals Inc.
  • 24236-202 Rifampin 300 mg by Remedyrepack Inc.
  • 24658-801 Rifampin 150 mg Oral Capsule by Puracap Laboratories LLC Dba Blu Pharmaceuticals
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 50090-0963 QR Code

< Prev: 50090-0962Next: 50090-0964 >

Related Discussions:

R Cinex Rifampin And Isoniazid Capsule U P S
I have been taking R Cinex Rifampin And Isoniazid Capsule U P S since last 67 days but I missed 1day dose,which doctor p... 3 replies
Side effects of Rifampin (rifampicin)
Hello, I would like to know if anyone is taking Rifampin and what are side effects, i read about it online but would lik... 1 reply
rifampin 150mg tablet availability
I need to locate the above mentioned medicine. I can not locate this drug in tablet form locally. Can anyone tell me abo...
rifampin
infection...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.